In Other News

• FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

• New Blood Biomarker Predicts May Predict Preeclampsia and Fetal Growth Restriction

• Automated System Streamlines DNA Recovery for MRD-Sensitive Testing

• Researchers Identify Shared Molecular Networks Behind Fatigue-Related Illnesses

• New Immune Target Could Support More Precise High Blood Pressure Treatment

• New Immune Target Could Support More Precise High Blood Pressure Treatment

• Researchers Identify Shared Molecular Networks Behind Fatigue-Related Illnesses

• New Liquid Biopsy Platform Uses Red Blood Cells to Detect Hidden Cancer Signals

• Urine Genomic Test Detects More Than Nine in Ten Suspected Bladder Cancers

• Label-Free Imaging Reveals Hidden Immune Activity in Blood Samples

• AI Tool Improves Prediction of Immunotherapy Response in Lung Cancer

• Liquid Biopsy Test Predicts Tissue of Origin in Cancer of Unknown Primary

• Study Identifies Genetic Marker Missing from Common Pharmacogenomic Panels

• Biomarker Score Helps Differentiate Takotsubo Syndrome from Myocardial Infarction

• New Biomarker Recommendations Aim to Personalize Stroke Rehabilitation

• New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers

• Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

• New Cellular Map May Help Predict Crohn’s Disease Course in Children

• New Cellular Map May Help Predict Crohn’s Disease Course in Children

• Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada

• Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes

• NIH-Funded Study Targets Saliva-Based Long COVID Diagnosis

• Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment